| A multisociety Delphi consensus statement on new fatty liver disease nomenclature ME Rinella, JV Lazarus, V Ratziu, SM Francque, AJ Sanyal, F Kanwal, ... Hepatology 78 (6), 1966-1986, 2023 | 2450 | 2023 |
| A placebo-controlled trial of obeticholic acid in primary biliary cholangitis F Nevens, P Andreone, G Mazzella, SI Strasser, C Bowlus, P Invernizzi, ... New England Journal of Medicine 375 (7), 631-643, 2016 | 1171 | 2016 |
| Elafibranor, an agonist of the peroxisome proliferator− activated receptor− α and− δ, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening V Ratziu, SA Harrison, S Francque, P Bedossa, P Lehert, L Serfaty, ... Gastroenterology 150 (5), 1147-1159. e5, 2016 | 1165 | 2016 |
| EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis GM Hirschfield, U Beuers, C Corpechot, P Invernizzi, D Jones, M Marzioni, ... Journal of hepatology 67 (1), 145-172, 2017 | 1080 | 2017 |
| Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited G Paumgartner, U Beuers Hepatology 36 (3), 525-531, 2002 | 989 | 2002 |
| Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review K Boonstra, U Beuers, CY Ponsioen Journal of hepatology 56 (5), 1181-1188, 2012 | 794 | 2012 |
| Population‐based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis K Boonstra, RK Weersma, KJ van Erpecum, EA Rauws, BWM Spanier, ... Hepatology 58 (6), 2045-2055, 2013 | 709 | 2013 |
| New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond U Beuers, M Trauner, P Jansen, R Poupon Journal of hepatology 62 (1), S25-S37, 2015 | 621 | 2015 |
| Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis U Beuers Nature clinical practice Gastroenterology & hepatology 3 (6), 318-328, 2006 | 567 | 2006 |
| Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo‐controlled trial U Beuers, U Spengler, W Kruis, ülker Aydemir, B Wiebecke, W Heldwein, ... Hepatology 16 (3), 707-714, 1992 | 557 | 1992 |
| Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis TJ Weismüller, PJ Trivedi, A Bergquist, M Imam, H Lenzen, CY Ponsioen, ... Gastroenterology 152 (8), 1975-1984. e8, 2017 | 509 | 2017 |
| Changing nomenclature for PBC: from ‘cirrhosis’ to ‘cholangitis’ U Beuers, EM Gershwin, RG Gish, P Invernizzi, DEJ Jones, K Lindor, ... Official journal of the American College of Gastroenterology| ACG 110 (11 …, 2015 | 469 | 2015 |
| Lysophosphatidic acid is a potential mediator of cholestatic pruritus AE Kremer, JJWW Martens, W Kulik, F Ruëff, EMM Kuiper, ... Gastroenterology 139 (3), 1008-1018. e1, 2010 | 456 | 2010 |
| Primary sclerosing cholangitis JK Dyson, U Beuers, DEJ Jones, AW Lohse, M Hudson The Lancet 391 (10139), 2547-2559, 2018 | 445 | 2018 |
| The biliary HCO3− umbrella: A unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies U Beuers, S Hohenester, LJM de Buy Wenniger, AE Kremer, PLM Jansen, ... Hepatology 52 (4), 1489-1496, 2010 | 413 | 2010 |
| Genome-wide association analysis in primary sclerosing cholangitis TH Karlsen, A Franke, E Melum, A Kaser, JR Hov, T Balschun, BA Lie, ... Gastroenterology 138 (3), 1102-1111, 2010 | 413 | 2010 |
| Intrahepatic cholestasis of pregnancy T Pusl, U Beuers Orphanet journal of rare diseases 2, 1-6, 2007 | 391 | 2007 |
| Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury C Lang, Y Meier, B Stieger, U Beuers, T Lang, R Kerb, GA Kullak-Ublick, ... Pharmacogenetics and genomics 17 (1), 47-60, 2007 | 378 | 2007 |
| A biliary HCO3− umbrella constitutes a protective mechanism against bile acid‐induced injury in human cholangiocytes S Hohenester, L Maillette de Buy Wenniger, CC Paulusma, SJ van Vliet, ... Hepatology 55 (1), 173-183, 2012 | 361 | 2012 |
| Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease SG Ji, BD Juran, S Mucha, T Folseraas, L Jostins, E Melum, N Kumasaka, ... Nature genetics 49 (2), 269-273, 2017 | 359 | 2017 |
